Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan

BACKGROUND: Real-world clinical data on psoriasis patients receiving different biological agents is needed, especially in Asian populations. OBJECTIVES: Our aim is to compare and analyze the efficacy and safety profile of four biological agents (etanercept, adalimumab, ustekinumab and secukinumab) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-Chen, Huang, Yi-Ting, Yang, Chao-Chun, Lai, Edward Chia-Cheng, Liu, Cheng-Han, Hsu, Chao-Kai, Wong, Tak-Wah, Chao, Sheau-Chiou, Sheu, Hamm-Ming, Lee, Chaw-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771674/
https://www.ncbi.nlm.nih.gov/pubmed/33373425
http://dx.doi.org/10.1371/journal.pone.0244620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771674/
https://www.ncbi.nlm.nih.gov/pubmed/33373425
http://dx.doi.org/10.1371/journal.pone.0244620

Ejemplares similares